# Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/protocol-deviations-for-clinical-investigations-of-drugs-biological-products-and-devices/12be365f-ede2-4671-b6b7-8da74c7c3635

> FDA guidance document: Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices. Issue date: December 30, 2024. Get complete insights and analysis.

---

## Details

- Title: Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-12-30
- Comment Close Date: 2025-02-28
- Last Changed: 2024-12-30
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-5016">FDA-2023-D-5016</a>

## Related Documents

- [Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/investigator-responsibilities-safety-reporting-for-investigational-drugs-and-devices-draft-guidance-for-industry/34f91048-9ac4-48e3-ac1e-4af23b426721)
- [Use of Data Monitoring Committees in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-data-monitoring-committees-in-clinical-trials/9d0ee35d-4fcc-4c44-88ac-f56c6a60187b)
- [Addressing Misinformation About Medical Devices and Prescription Drugs:  Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/addressing-misinformation-about-medical-devices-and-prescription-drugs-questions-and-answers/d6c8e69d-781e-4fe8-b28c-d3e357829a89)